Founded in 1944 as a groundbreaking laboratory for dermatological test kits, TKL Research has evolved into a full-service solutions provider defined by over eight decades of scientific continuity. While our roots are in the skin, our clinical rigor extends across complex therapeutic landscapes. Backed by 80+ years of independent stability, we deliver the scientific agility that rigid corporate CROs cannot...
TKL Research is a solutions provider. We haven't built our legacy on solely running clinical research studies; we've built TKL as a full service machine. Start to finish, we offer a la carte services that are available to our sponsors as needed. We don't just give you data; we give you the path forward. Phase I-IV End-to-End Early Phase Solution ...
Evolution is key in this industry. Yes, one must continuously be evolving scientifically and up on all of the latest technology trends, but relentlessly refining operational efficiency is just as important - the key to longevity is to create balance. At TKL, we have bridged the gap between complex science and operational scale by building our own dedicated 50-bed Clinical Pharmacology...
Working in this competitive landscape, filled with mergers and very large CROs, it is an honor to be recognized by Pharma Tech Outlook as a Top CRO. TKL Research was founded over 75 years ago and has since weathered many storms. We always strive to be the best, the most knowledgeable, the most efficient and flexible in order to offer...
The New Design Standard for Clinical Trials. Based on a 2013 study with Novartis for BioMedical Research, TKL Research developed a study that was approved and accepted by the FDA as a comprehensive design to test the photosensitization potential of the investigational product...
Things have been busy at TKL Research. Our clinical studies team recently wrapped up a study with Sun Pharmaceuticals evaluating the taste, grittiness and overall acceptability of Metformin HCl extended release powder in various flavors vs the current immediate release tablets and oral suspension. The problems surrounding the current formulation of the immediate release tablets and oral suspension were the inconvenient...
TKL Research is excited to announce the launch of our new mobile application for subject recruitment and retention....
